SNPS Add to watchlist $475.62 5.02 (-1.04%) Last updated: May 31, 2026 03:47
52-Week Range
$475.62
$376.18 $475.62 $651.73

Fundamentals Overview

Synopsys, Inc. is in the middle of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 117.9 P/B 2.97 P/S 10.49

Intrinsic value (DCF)

-48.1% downside vs price

Profitability

Net margin 8.9%

Risk (Beta)

1.25 — higher vol

Earnings & growth

EPS $4.04 Rev -5.5% Profit -73.6% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 56% confidence Risk: High Volatility — Beta 1.25. Consider smaller position size due to higher beta.

Supporting (Buy):

Analyst grade: B- · Sentiment improving (3 upgrades)

Pressures (Sell):

DCF 48.1% downside vs price · 3M vs Technology sector: -27.7%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$91.07B
P/E (TTM)
117.87
EPS (TTM)
$4.04
Dividend Yield
N/A
52-Week Range
$376.18 - $651.73
Volume vs Avg
N/A
Beta
1.25

About

Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. The company offers Fusion Design Platform that provides digital design implementation solutions; Verification Continuum Platform that provides virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions. It also prov...
Sector: Technology
Headquarters: US
Employees: 28,000
IPO Date: Feb 1992
Beta: 1.25 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: B-. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 13, Equal Weight: 7, Neutral: 4, Overweight: 5, Underperform: 1.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $246.70; current price is $475.62. That’s a -48.1% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 117.87
DCF value (model) $246.70 (-48.1% vs price)
PEG (TTM) N/A
P/B (TTM) 2.97
P/S (TTM) 10.49
P/FCF (TTM) 34.58
Liquidity & enterprise
Current Ratio (TTM) 1.43
Quick Ratio (TTM) 1.32
Cash Ratio (TTM) 0.64
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 8.9%
Gross margin (TTM) 73.47%
Operating margin (TTM) 7.03%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for SNPS.

Analyst Sentiment at a Glance

B- Sentiment Improving
Buy 13Equal Weight 7Neutral 4Overweight 5Underperform 1
3 upgrades, 2 downgrades
Price Target Consensus
Current $475.62
Median $569.00
Consensus $553.60
Low consensus $450.00
High consensus $633.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
B of A Securities maintain Buy Buy 2026-05-28
Wells Fargo maintain Equal Weight Equal Weight 2026-05-28
Needham maintain Buy Buy 2026-05-28
Citigroup maintain Buy Buy 2026-05-28
Rosenblatt maintain Buy Buy 2026-05-28
Morgan Stanley maintain Equal Weight Equal Weight 2026-05-28
Piper Sandler maintain Neutral Neutral 2026-05-28
BNP Paribas maintain Underperform Underperform 2026-05-28
Stifel maintain Buy Buy 2026-05-28
Rosenblatt maintain Buy Buy 2026-05-26
Wells Fargo maintain Equal Weight Equal Weight 2026-05-14
Citigroup maintain Buy Buy 2026-05-13
Morgan Stanley downgrade Overweight Equal Weight 2026-02-27
Piper Sandler maintain Neutral Neutral 2026-02-26
Wells Fargo maintain Equal Weight Equal Weight 2026-02-26
Rosenblatt maintain Buy Buy 2026-02-26
Rosenblatt maintain Buy Buy 2026-02-20
Piper Sandler downgrade Overweight Neutral 2026-01-13
Morgan Stanley maintain Overweight Overweight 2025-12-12
Rosenblatt maintain Buy Buy 2025-12-11
Piper Sandler maintain Overweight Overweight 2025-12-11
Needham maintain Buy Buy 2025-12-11
B of A Securities upgrade Neutral Buy 2025-12-11
JP Morgan maintain Overweight Overweight 2025-12-11
Wells Fargo maintain Equal Weight Equal Weight 2025-12-11
Keybanc maintain Overweight Overweight 2025-12-11
Rosenblatt upgrade Neutral Buy 2025-12-09
B of A Securities upgrade Underperform Neutral 2025-12-08
Keybanc maintain Overweight Overweight 2025-12-03
Wells Fargo maintain Equal Weight Equal Weight 2025-11-25